to study the effect of sucralfate cream on pain in patients undergoing fistulectony

EFFECT OF TOPICAL SUCRALFATE CREAM ON PAIN FOLLOWING FISTULECTOMY-A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020455

Enrollment

Registered

2019-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: 7% SUCRALFATE CREAM: 7%V SUCRALFATE CREAM SHALL BE USED IN POST OPERATIVE FISTULECTOMY WOUND TO ASSESS THE PAIN RELIEF AND ENHANCE THE WOUND HEALING Control Intervention1: VASELINE: VAS

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH A LOW FISTULA

Exclusion criteria

Exclusion criteria: PREVIOUS FISTULA SURGERY MULTIPLE FISTULAS COMPLEX FISTULA IN ANO PATIENTS WITH INFLAMMATORY BOWEL DISEASE LONG TERM USE OF CORTICOSTEROIDS POORLY CONTROLLED DIABETES MELLITUS PATIENTS WITH A HISTORY OF RADIATION EXPOSURE RECENT HISTORY OF CHEMOTHERAPY( <2 WEEKS)

Design outcomes

Primary

Measure	Time frame
TO STUDY THE EFFECT OF SUCRALFATE CREAM IN PAIN RELIEF IN PATIENTS UNDERGOING FISTULECTOMYTimepoint: DURING POST OPERATIVE PERIOD, 1ST WEEK, 2ND WEEK, 4TH WEEK AND 6TH WEEK OF POSTOPERATIVE PERIOD	—

Secondary

Measure	Time frame
TO ASSESS THE ROLE OF SUCRALFATE IN WOUND HEALING IN POST FISTULECTOMY WOUNDSTimepoint: IN POST OPERATIVE PERIOD, 1ST WEEK, 2ND WEEK, 4TH WEEK, 6TH WEEK	—

Countries

India

Contacts

Public ContactDR SANGRAM KIESHARI PATRO

jipmer

drbalak@gmail.com9443617089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026